PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,058.00
Bid: 12,054.00
Ask: 12,058.00
Change: -52.00 (-0.43%)
Spread: 4.00 (0.033%)
Open: 12,090.00
High: 12,116.00
Low: 12,038.00
Prev. Close: 12,110.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European shares end higher on upbeat German data

Wed, 24th Feb 2021 17:04

* German Q4 GDP grows more than expected

* AstraZeneca to deliver fewer-than-expected vaccines to EU

* Sportswear maker Puma drops as lockdowns affect sales

* Norway's Bakkafrost bottoms out STOXX 600
(Updates to market close)

By Shashank Nayar and Ambar Warrick

Feb 24 (Reuters) - European shares rose on Wednesday as
sectors primed to benefit from economic recovery were supported
by strong German growth data, although concerns over a possible
rise in inflation and lofty equity valuations kept gains in
check.

The pan-European STOXX 600 ended 0.5% higher, with
Germany's DAX adding 0.8% as data showed bullish
exports and solid construction activity helped Europe's biggest
economy to grow by a stronger-than-expected 0.3% in the fourth
quarter.

Travel stocks jumped 1.9% to near one-year highs,
leading European sector gains on optimism around major countries
lifting coronavirus-induced lockdowns.

Still, global airline industry body IATA flagged further
headwinds for airlines in 2021.

"The market has fallen recently due to lofty valuations, but
investors are becoming more accepting of the fact that as
European economies slowly reopen and earnings improve, the
current equity valuations could be justified," said Chris
Beauchamp, chief market analyst at IG Group.

The benchmark STOXX 600 has rebounded nearly 50% from its
March 2020 lows, also led by historic stimulus measures, but it
has still far underperformed a 75% jump in the U.S. S&P 500
.

U.S. Federal Reserve Chair Jerome Powell reiterated on
Tuesday that interest rates will remain low despite indications
of rising inflation, assuaging some fears of a sudden tapering
in monetary stimulus.

"While another stimulus package will certainly be welcomed
by market participants, inflation fears are still present,
despite those concerns being downplayed by officials," said
Milan Cutkovic, market analyst at Axi.

"As more countries are planning the reopening of their
economies, the focus could slowly shift back to value stocks."

The rotation out growth-driven stocks was apparent, with the
technology sector losing nearly 4% this week, lagging
all of its regional peers.

In company news, AstraZeneca dipped 0.2% after it
told the European Union that it expects to deliver less than
half the COVID-19 vaccines it was contracted to supply in the
second quarter.

Norwegian salmon farmer Bakkafrost was the
biggest percentage loser on the STOXX 600 for a second session
after it posted a fourth-quarter loss due to the pandemic.

German sportswear company Puma dropped 2.1% after
saying it expects a heavy impact on its results from lockdowns
through the end of the second quarter.

Telecom Italia surged 9.2% after it said profit
and sales should stabilise this year.
(Reporting by Shashank Nayar in Bengaluru; Editing by Saumyadeb
Chakrabarty and Uttaresh.V and Kirsten Donovan)

More News
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.